Application YC di Keylika

Summer 2022Active

Keylika ha partecipato a Y Combinator nel batch Summer 2022 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2022
Settore: HealthcareTherapeutics
Dimensione team: 1
Stato: Active
Lanciata: 2022

Founder

Buddha ChaudhuriFounder
Frederik CeyssensFounder

Cosa fa Keylika

Keylika is an early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. We then administer these drugs using proven delivery technologies to effect the best clinical outcomes. Our first product is a small molecule iron drug (new molecular entity) delivered by a wearable skin patch to treat Iron Deficiency Anemia (IDA), with significantly higher safety, efficacy and tolerability over existing treatments. This is poised to be a best-in-class, potentially breakthrough therapy for treating iron deficiency without any GI side-effects (eg. nausea, constipation, diarrhea, etc.) typically associated with oral iron supplements, and without the risks, costs and side-effects associated with IV iron infusions. When approved, Keylika’s proprietary transdermal iron will be the world's first prescription iron patch. Iron deficiency is a hugely understated problem affecting about 1.6 billion people worldwide and more than 30 million in the US alone, translating to a $17B US market.

Application YC di Keylika, ricostruita

Domanda per Y Combinator

Keylika, batch Summer 2022. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Keylika

Describe what your company does in 50 characters or less.

Redefining the Standard of Care for Iron Deficiency Anemia

What is your company going to make? Please describe your product and what it does or will do.

We develop metal-based drugs using our platform synthesis technology and deliver them via proven methods. Our first product is a wearable skin patch that delivers a new molecular iron drug for Iron Deficiency Anemia with fewer side effects than oral or IV treatments.

Where do you live now, and where would the company be based after YC?

We live in Walnut Creek, CA, and plan to keep the company based here after YC.

Explain your decision regarding location.

We are already based in Walnut Creek near the Bay Area's biotech and healthcare ecosystem, which suits our access to talent and partners.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Keylika?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Keylika (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Keylika si presenterebbe a YC, non il testo che hanno inviato.